TCL Archive Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen. February 2, 2007
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors November 24, 2006